Prothena Corporation PLC
Change company Symbol lookup
Select an option...
PRTA Prothena Corporation PLC
IDTI Integrated Device Technology Inc
TWOU 2U Inc
JBK Goldman Sachs Capital I Securities-Backed Series 2004-6 Trust
NAUBF National Australia Bank Ltd
YRCW YRC Worldwide Inc
MNRK Monarch Financial Holdings Inc
RM Regional Management Corp
TREC Trecora Resources
CLR Continental Resources Inc
Go

Health Care : Biotechnology | Small Cap Growth
Based in IrelandCompany profile

Prothena Corporation Public Limited Company is an Ireland-based, late-stage clinical biotechnology company. The Company is focused on the discovery, development and commercialization of protein immunotherapy programs for the treatment of diseases that involve amyloid or cell adhesion. The Company's research and development pipeline includes three therapeutic antibody programs, such as NEOD001 for the treatment of AL amyloidosis; PRX002 in collaboration with Roche, for the treatment of Parkinson's disease and other related synucleinopathies, and PRX003 for the treatment of psoriasis and other inflammatory diseases. The Company's pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of diseases related to amyloid or cell adhesion.

Postmarket

Last Trade
Delayed
$34.27
-0.0041 (-0.01%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$34.27
Day's Change
-2.50 (-6.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
38.20
Day's Low
33.70
Volume
(Heavy Day)
Volume:
1,375,240
10-day average volume:
782,000
1,375,240
  • Prev Close
    36.77
  • Today's Open
    36.71
  • Day's Range
    33.70-38.20
  • Avg Vol (10-day)
    782.0K
  • Last (time)
    4:00p ET 02/05/16
  • Last (size)
    48.4K
  • 52-Wk Range
    20.60 - 76.42
    LowHigh
  • (02/05/15 - 11/30/15)
    66.33%
  • 72.5%
  • Market Cap
    938.2M
  • Shares Outstanding
    27.4M
  • -2.36
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 97.45
  • (% of float 01/15/16)
    6.20

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.